GlobeNewswire Inc.··DelveinsightiPSC-Derived NK Cell Therapies Accelerate With 12+ Companies Advancing Pipeline
12+ companies advance iPSC-derived NK cell therapies for cancer treatment. Century Therapeutics and Fate Therapeutics report promising clinical progress in this expanding immunotherapy field.
IPSCFATEHLOSFclinical trialscancer treatment